Adam Nelson MBBS MBA MPH PhD is an interventional and preventative cardiologist appointed to the Royal Adelaide and Queen Elizabeth Hospitals and the University of Adelaide where he is the head of the Cardiometabolic Clinical Trial Unit. Adam is the chair of the CSANZ Prevention Council and Academic Lead of the Asia Pacific Cardiometabolic Consortium. Adam is on the national or global leadership of multiple trials evaluating emerging therapies for dyslipidaemia, obesity and diabetes. He is the recipient of >$10millon of peer-reviewed grant funding and received the Shirley Hamilton Award for the National Heart Foundation top ranked post-doctoral fellowship candidate. He has over 200 publications and book chapters but is most proud of his two boys, Archer and Max.